Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 19, 2025 08:30 ET | Source: Conduit Pharmaceuticals

Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904

Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904
March 06, 2025 09:35 ET | Source: Conduit Pharmaceuticals

Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel

Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel
February 20, 2025 08:00 ET | Source: Conduit Pharmaceuticals

Conduit Progresses Phase II of its AI Initiative with Sarborg

Conduit Progresses Phase II of its AI Initiative with Sarborg
February 13, 2025 08:00 ET | Source: Conduit Pharmaceuticals

Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model

Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model
February 11, 2025 09:00 ET | Source: Conduit Pharmaceuticals

Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note

Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note
February 07, 2025 08:00 ET | Source: Conduit Pharmaceuticals

Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development

Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development
January 28, 2025 05:30 ET | Source: Conduit Pharmaceuticals

Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence

Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence
January 23, 2025 08:00 ET | Source: Conduit Pharmaceuticals

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split
January 22, 2025 08:00 ET | Source: Conduit Pharmaceuticals

Conduit Pharmaceuticals Partners with Agility Life Sciences to Create Enhanced Formulations for its Autoimmune Pipeline

Conduit Pharmaceuticals Partners with Agility Life Sciences to Create Enhanced Formulations for its Autoimmune Pipeline
December 12, 2024 07:30 ET | Source: Conduit Pharmaceuticals

Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics

Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics Approach

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right